TELCON RF PHARMACEUTICAL. Inc. (KOSDAQ:200230)

South Korea flag South Korea · Delayed Price · Currency is KRW
636.00
-3.00 (-0.47%)
Apr 29, 2026, 3:30 PM KST
-55.05%
Market Cap 23.03B
Revenue (ttm) 43.16B
Net Income (ttm) -11.46B
Shares Out 36.05M
EPS (ttm) -239.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 576,689
Average Volume 2,094,356
Open 637.00
Previous Close 639.00
Day's Range 629.00 - 639.00
52-Week Range 598.00 - 4,433.33
Beta 0.72
RSI 38.31
Earnings Date May 15, 2026

About TELCON RF PHARMACEUTICAL.

TELCON RF PHARMACEUTICAL. Inc. primarily engages in the development, production, and sale of RF coaxial connectors worldwide. It also provides coaxial couplers, distributors, and arresters, as well as cable assemblies; and pharmaceuticals. The company was formerly known as Telcon Co., Ltd. TELCON RF PHARMACEUTICAL. Inc. was founded in 1999 and is headquartered in Yongin-si, South Korea. [Read more]

Sector Technology
Founded 1999
Employees 126
Stock Exchange KOSDAQ
Ticker Symbol 200230
Full Company Profile

Financial Performance

In 2025, TELCON RF PHARMACEUTICAL.'s revenue was 43.16 billion, an increase of 13.99% compared to the previous year's 37.87 billion. Losses were -11.46 billion, -56.48% less than in 2024.

Financial Statements

News

There is no news available yet.